Indeed, it has been demonstrated that treatment with PPAR-α agonists increases LC3 protein levels in fed mice101 as well as transcript levels of autophagic genes in a murine model of acute liver failure, leading to an active autophagic flux102. The gene discussed is MAP1LC3A; the disease is acute liver failure.